1. Sweden Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Midsona AB Class A

Midsona AB Class A

14.70
SEK
0.00
(0.00%)
0.77EPS
19.74P/E
2.21BMarket Cap
Midsona AB Class A
STO:MSON_A
(Nasdaq Stockholm)

Recent

price

14.70

P/E

ratio

19.74

div

yld

2.85%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
SEK
29.38
26.69
22.52
23.74
23.84
30.75
42.65
37.5
55.12
56.86
50.73
55.66
52.37
26.08
25.63
24.96
24.49
Revenue per Share
-1.74
0.83
0.91
1.32
1.63
1.73
1.1
1.47
2.49
1.79
2.41
1.31
-6.73
-0.36
0.32
0.07
0.77
Basic EPS, GAAP
0.41
0.49
1.14
2.1
1.37
2.2
0.51
2.18
2.88
2.9
2.67
-1.81
2.26
2.15
0.81
1.34
1.04
Free Cash Flow per Basic Share
- -
- -
- -
0.29
0.6
0.65
0.76
0.82
1.12
1.07
1.11
1.27
- -
- -
- -
0.2
0.42
Dividend per Share
961.8
20.87
21.96
22.72
24.04
23.73
28.06
29.89
31.44
35.67
35.53
39.52
21.19
20.54
21.1
20.17
21.11
Book Value per Share
-228.04
-4.13
-5.41
-4.35
-3.97
-5.14
-12.29
-11.17
-16.12
-11.31
-14.99
-6.72
0.43
0.42
1.11
1.11
1.6
Tangible Book Value per Share
39
39
39
39
39
38
41
57
52
54
73
68
74
145
145
145
145
Basic Weighted Avg Shares
1,134
1,030
869
916
920
1,174
1,744
2,146
2,852
3,081
3,709
3,773
3,899
3,793
3,727
3,630
3,561
Sales/Revenue/Turnover
-4.41
4.27
4.83
6.99
6.63
4.17
5.22
6.52
6.8
6.17
6.79
4.37
-11.8
0.55
3.49
1.46
4.24
Operating Margin (%)
- -
16
14
14
14
19
25
35
52
114
147
156
161
157
152
142
- -
Depreciation Expense
-67
32
35
51
63
66
45
84
129
97
176
89
-501
-53
47
10
112
Net Income, GAAP
- -
6.25
- -
3.77
- -
- -
22.41
25
20.86
16.38
13.73
22.61
- -
- -
37.33
58.33
8.94
Effective Tax Rate (%)
-5.91
3.11
4.03
5.57
6.85
5.62
2.58
3.91
4.52
3.15
4.75
2.36
-12.85
-1.4
1.26
0.28
3.15
Profit Margin (%)
122
97
76
55
51
67
177
152
310
399
293
566
621
500
483
656
742
Working Capital
262
214
212
149
148
250
696
665
1,124
1,408
1,526
1,314
776
608
465
550
541
LT Debt
620
652
686
710
751
877
1,349
1,550
1,630
2,322
2,313
2,875
3,082
2,987
3,068
2,933
3,070
Total Equity
- -
-33.04
- -
6.7
- -
- -
3.83
4.58
5.47
4.22
5.54
2.92
- -
- -
2.16
0.67
3.81
Return on Invested Capital (%)
- -
5.25
- -
6.6
- -
- -
3.56
4.5
5.86
3.8
5.17
2.8
- -
- -
2.06
0.64
3.97
Return on Capital (%)
-10.1
5.03
5.23
7.31
8.62
8.11
4.04
5.8
8.11
4.91
7.59
3.43
-16.82
-1.75
1.55
0.33
3.7
Return on Common Equity (%)

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
65
61
58
LT Borrowings
491
- -
- -
LT Finance Leases
59
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
145
145
145
Market Capitalization
1,556
1,760
2,211

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,251
1,376
1,313
Cash, Cash Equivalents & STI
316
340
282
Accounts Receivable, Net
327
393
325
Inventories
552
592
641
Total Current Liabilities
595
603
571
Payables & Accruals
- -
- -
- -
ST Debt
65
61
58
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.27%
5.35%
-4.4%
Free Cash Flow
15.81%
-62.18%
65.25%
Net Income, GAAP
-90.41%
-213.83%
-78.72%
Sales/Revenue/Turnover
13.09%
-0.4%
-2.6%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
929
918
919
961
3,727
2025
937
865
- -
933
3,630
2026
893
870
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
0.02
0.06
0.13
0.32
2025
0.05
-0.1
- -
0.23
0.07
2026
0.56
0.08
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
0.2
- -
- -
0.2
2026
- -
0.22
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Midsona AB (publ) develops, manufactures and markets health and well-being products, with a focus on organic, plant-based and natural foods; it operates primarily in the consumer health and wellness industry through three divisions covering Nordics, North Europe and South Europe. The company offers a broad portfolio of products including plant-based foods such as grains, flakes, seeds, vegetables, pasta, rice, nuts, dried fruits, berries, oils, spices, muesli and fruit purees under brands like Earth Control and Kung Markatta; organic and vegan beauty products encompassing hair, body and face care under Urtekram and Urtekram Beauty; roasted grains, cereals, corn and rice cakes, teas and dietary supplements under Friggs and Davert; vegetable proteins and fresh plant-based items under Vegetalia; cooking and baking essentials like oils, grains, pasta, bouillon and flours under Celnat; as well as organic and biodynamic goods including breads, beverages, cold cuts, pasta sauces, pesto, sugar, syrups, nuts, seeds and tea under Helios and Happy Bio. Midsona sells these products through pharmacies, grocery chains, health food stores, food service operators and online channels to consumers seeking healthy, sustainable alternatives. Founded in 1892 and headquartered in Malmö, Sweden, the company maintains a strong presence in the Nordic countries (Sweden, Denmark, Finland, Norway), with expanding operations in Germany, France and Spain. In recent developments, Midsona announces a restructuring program in October 2025 to streamline operations, reduce overhead costs and accelerate margin improvements, targeting annual savings of SEK 20 million by Q1 2026 with related costs of SEK 15 million; this follows improved Q3 2025 profitability, with EBIT up 40% year-over-year to SEK 45 million and own-brand organic sales growth of 8.2%, despite a 2.6% overall net sales decline due to currency effects and Spanish capacity issues.